| Clinical features, management, and outcomes of immune checkpoint inhibitor–related cardiotoxicity M Escudier, J Cautela, N Malissen, Y Ancedy, M Orabona, J Pinto, ... Circulation 136 (21), 2085-2087, 2017 | 442 | 2017 |
| Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification AM Leader, JA Grout, BB Maier, BY Nabet, MD Park, A Tabachnikova, ... Cancer cell 39 (12), 1594-1609. e12, 2021 | 176 | 2021 |
| Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery C Gaudy-Marqueste, AS Dussouil, R Carron, L Troin, N Malissen, ... European Journal of Cancer 84, 44-54, 2017 | 82 | 2017 |
| Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions S Le Guellec, N Macagno, V Velasco, L Lamant, M Lae, T Filleron, ... Modern Pathology 30 (12), 1677-1687, 2017 | 77 | 2017 |
| Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma A Magen, P Hamon, N Fiaschi, BY Soong, MD Park, R Mattiuz, E Humblin, ... Nature medicine 29 (6), 1389-1399, 2023 | 63 | 2023 |
| Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: a prospective study of 25 patients N Malissen, L Vergely, M Simon, A Roubertie, MC Malinge, D Bessis Journal of the American Academy of Dermatology 77 (3), 464-472. e3, 2017 | 51 | 2017 |
| Metastatic melanoma: recent therapeutic progress and future perspectives N Malissen, JJ Grob Drugs 78 (12), 1197-1209, 2018 | 47 | 2018 |
| HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma N Malissen, N Macagno, S Granjeaud, C Granier, V Moutardier, ... Oncoimmunology 8 (12), e1665976, 2019 | 43 | 2019 |
| Diabetes and blood glucose disorders under anti-PD1 Q Magis, C Gaudy-Marqueste, A Basire, A Loundou, N Malissen, L Troin, ... Journal of Immunotherapy 41 (5), 232-240, 2018 | 37 | 2018 |
| Macrophage activation syndrome: a new complication of checkpoint inhibitors N Malissen, J Lacotte, A Du-Thanh, C Gaudy-Marqueste, B Guillot, ... European Journal of Cancer 77, 88-89, 2017 | 31 | 2017 |
| A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule M Nollet, J Stalin, A Moyon, W Traboulsi, A Essaadi, S Robert, N Malissen, ... Oncotarget 8 (68), 112283, 2017 | 29 | 2017 |
| Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy R Carron, C Gaudy-Marqueste, F Amatore, L Padovani, N Malissen, ... European Journal of Cancer 135, 52-61, 2020 | 28 | 2020 |
| The scalp hair collar and tuft signs: A retrospective multicenter study of 78 patients with a systematic review of the literature D Bessis, M Bigorre, N Malissen, G Captier, C Chiaverini, C Abasq, ... Journal of the American Academy of Dermatology 76 (3), 478-487, 2017 | 24 | 2017 |
| Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study A Weill, J Delyon, V Descamps, L Deschamps, M Dinulescu, A Dupuy, ... Rheumatology 60 (12), 5753-5764, 2021 | 22 | 2021 |
| Study of metastatic kinetics in metastatic melanoma treated with B-RAF inhibitors: Introducing mathematical modelling of kinetics into the therapeutic decision N Hartung, CTK Huynh, C Gaudy-Marqueste, A Flavian, N Malissen, ... PLoS One 12 (5), e0176080, 2017 | 12 | 2017 |
| Identification of an immature subset of PMN-MDSC correlated to response to checkpoint inhibitor therapy in patients with metastatic melanoma F Gondois-Rey, M Paul, F Alcaraz, S Bourass, J Monnier, N Malissen, ... Cancers 13 (6), 1362, 2021 | 11 | 2021 |
| Cross-cultural adaptation into French and validation of the SCAR-Q questionnaire T Radulesco, J Mancini, M Penicaud, JJ Grob, MA Richard, P Dessi, ... Quality of Life Research 30, 1225-1231, 2021 | 9 | 2021 |
| Intratumoral mregDC and CXCL13 T helper niches enable local differentiation of CD8 T cells following PD-1 blockade A Magen, P Hamon, N Fiaschi, L Troncoso, E Humblin, D D’souza, ... BioRxiv, 2022.06. 22.497216, 2022 | 8 | 2022 |
| Clinical impact of high throughput sequencing on liquid biopsy in advanced solid cancer E Gouton, N Malissen, N André, A Jeanson, A Pelletier, A Testot-Ferry, ... Current Oncology 29 (3), 1902-1918, 2022 | 7 | 2022 |
| HVEM: A novel cosignaling molecule of major interest in melanoma. N Malissen, N Macagno, S Granjeaud, C Granier, V Moutardier, ... Journal of Clinical Oncology 35 (15_suppl), e14591-e14591, 2017 | 7 | 2017 |
